Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk FactorsKelsey, Chris R., M.D ; Horwitz, Mitchell E., M.D ; Chino, Junzo P., M.D ; Craciunescu, Oana, Ph.D ; Steffey, Beverly, M.S ; Folz, Rodney J., M.D. Ph.D ; Chao, Nelson J., M.D ; Rizzieri, David A., M.D ; Marks, Lawrence B., M.DInternational journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.812-818 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
|
2 |
Material Type: Artigo
|
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host DiseaseLin, Chenyu ; DiCioccio, Rachel A. ; Haykal, Tarek ; McManigle, William C. ; Li, Zhiguo ; Anand, Sarah M. ; Poe, Jonathan C. ; Bracken, Sonali J. ; Jia, Wei ; Alyea, Edwin P. ; Cardones, Adela R. ; Choi, Taewoong ; Gasparetto, Cristina ; Grunwald, Michael R. ; Hennig, Therese ; Kang, Yubin ; Long, Gwynn D. ; Lopez, Richard ; Martin, Melissa ; Minor, Kerry K. ; Quinones, Victor L. Perez ; Sung, Anthony D. ; Wiggins, Kristi ; Chao, Nelson J. ; Horwitz, Mitchell E. ; Rizzieri, David A. ; Sarantopoulos, StefanieTransplantation and cellular therapy, 2023-03, Vol.29 (3), p.179.e1-179.e10 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
3 |
Material Type: Artigo
|
Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analysesLin, Tara L. ; Rizzieri, David A. ; Ryan, Daniel H. ; Schiller, Gary J. ; Kolitz, Jonathan E. ; Uy, Geoffrey L. ; Hogge, Donna E. ; Solomon, Scott R. ; Wieduwilt, Matthew J. ; Ryan, Robert J. ; Faderl, Stefan ; Cortes, Jorge E. ; Lancet, Jeffrey E.Blood advances, 2021-03, Vol.5 (6), p.1719-1728 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
4 |
Material Type: Artigo
|
Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AMLde Botton, Stéphane ; Cluzeau, Thomas ; Vigil, Carlos ; Cook, Rachel J. ; Rousselot, Philippe ; Rizzieri, David A. ; Liesveld, Jane L. ; Fenaux, Pierre ; Braun, Thorsten ; Banos, Anne ; Jurcic, Joseph G. ; Sekeres, Mikkael A. ; Savona, Michael R. ; Roboz, Gail J. ; Bixby, Dale ; Madigan, Kate ; Volkert, Angela ; Stephens, Kristin ; Kang-Fortner, Qing ; Baker, Kristen ; Paul, Sofia ; McKeown, Michael ; Carulli, John ; Eaton, Matthew ; Hodgson, Graeme ; Fiore, Christopher ; Kelly, Michael J. ; Roth, David A. ; Stein, Eytan M.Blood advances, 2023-05, Vol.7 (9), p.1858-1870 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
5 |
Material Type: Artigo
|
Pulmonary sarcoidosis following stem cell transplantation: Is it more than a chance occurrence?BHAGAT, Rajesh ; RIZZIERI, David A ; VREDENBURGH, James J ; CHAO, Nelson J ; FOLZ, Rodney JChest, 2004-08, Vol.126 (2), p.642-644 [Periódico revisado por pares]Northbrook, IL: American College of Chest PhysiciansTexto completo disponível |
|
6 |
Material Type: Artigo
|
Zevalin® (ibritumomab tiuxetan): After More Than a Decade of Treatment Experience, What Have We Learned?Rizzieri, DavidCritical reviews in oncology/hematology, 2016-09, Vol.105, p.5-17 [Periódico revisado por pares]Netherlands: Elsevier Ireland LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 studyIssa, Jean-Pierre J, Prof ; Roboz, Gail, Prof ; Rizzieri, David, Prof ; Jabbour, Elias, MD ; Stock, Wendy, Prof ; O'Connell, Casey, MD ; Yee, Karen, MD ; Tibes, Raoul, MD ; Griffiths, Elizabeth A, MD ; Walsh, Katherine, MD ; Daver, Naval, MD ; Chung, Woonbok, PhD ; Naim, Sue, BS ; Taverna, Pietro, PhD ; Oganesian, Aram, PhD ; Hao, Yong, MD ; Lowder, James N, MD ; Azab, Mohammad, MD ; Kantarjian, Hagop, ProfThe lancet oncology, 2015-09, Vol.16 (9), p.1099-1110 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trialKantarjian, Hagop M ; Roboz, Gail J ; Kropf, Patricia L ; Yee, Karen W L ; O'Connell, Casey L ; Tibes, Raoul ; Walsh, Katherine J ; Podoltsev, Nikolai A ; Griffiths, Elizabeth A ; Jabbour, Elias ; Garcia-Manero, Guillermo ; Rizzieri, David ; Stock, Wendy ; Savona, Michael R ; Rosenblat, Todd L ; Berdeja, Jesus G ; Ravandi, Farhad ; Rock, Edwin P ; Hao, Yong ; Azab, Mohammad ; Issa, Jean-Pierre JThe lancet oncology, 2017-10, Vol.18 (10), p.1317-1326 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicityStephens, Sarah J., MD ; Thomas, Samantha, MB ; Rizzieri, David A., MD ; Horwitz, Mitchell E., MD ; Chao, Nelson J., MD ; Engemann, Ashley M., PharmD ; Lassiter, Martha, MSN ; Kelsey, Chris R., MDAdvances in radiation oncology, 2016-10, Vol.1 (4), p.272-280 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
10 |
Material Type: Artigo
|
Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant PatientsRacioppi, Alessandro ; Dalton, Tara ; Ramalingam, Sendhilnathan ; Romero, Kristi ; Ren, Yi ; Bohannon, Lauren ; Arellano, Consuelo ; Jonassaint, Jude ; Miller, Hilary ; Barak, Ian ; Fish, Laura J. ; Choi, Taewoong ; Gasparetto, Cristina ; Long, Gwynn D. ; Lopez, Richard D. ; Rizzieri, David A. ; Sarantopoulos, Stefanie ; Horwitz, Mitchell E. ; Chao, Nelson J. ; Shah, Nirmish R. ; Sung, Anthony D.Transplantation and cellular therapy, 2021-02, Vol.27 (2), p.181.e1-181.e9 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |